Bioresorbable Implants Market Size, Share, Growth, and Industry Analysis, By Type (Metals and Polymers), By Application (Stents, Orthopedics and Others), Regional Insights and Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

BIORESORBABLE IMPLANTS MARKET OVERVIEW

The global bioresorbable implants market size is anticipated to be valued at USD 6.82 Billion in 2026, with a projected growth to USD 10.05 Billion by 2035 at a CAGR of 4.4% during the forecast from 2026 to 2035.

Bioresorbable implants are medical devices that are made from materials that are eventually broken down and absorbed by the body. These implants are used in a variety of applications. Stents are used to keep blood vessels open. Bioresorbable stents are gradually absorbed by the body over a period of months or years. This reduces the risk of complications such as infection and inflammation, which are common with traditional metal stents.

Bioresorbable stents are made from materials such as polylactic acid (PLA) and polyglycolic acid (PGA). These materials are naturally occurring and biocompatible, meaning that they are not harmful to the body. Bioresorbable stents are also flexible and strong, which makes them suitable for use in blood vessels.

KEY FINDINGS

COVID-19 IMPACT

Pandemic Decreased The Market Demand Due To Non-Prioritization Of Elective Surgeries

The global COVID-19 pandemic has been unprecedented and staggering, with the bioresorbable implants market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.

The COVID-19 pandemic had a significant impact on the bioresorbable implants market share. During the pandemic, many hospitals and healthcare facilities had to postpone or cancel elective surgeries due to the need to prioritize the treatment of COVID-19 patients. This led to a decline in the demand for them, which are typically used in elective surgeries. The COVID-19 pandemic also caused disruptions to the supply chain for them. This was due to factors such as factory closures, travel restrictions, and delays in transportation. These disruptions made it difficult for manufacturers to get the materials and components they need to produce them. The COVID-19 pandemic also led to an economic slowdown, which reduced the disposable income of many people. This made it more difficult for people to afford elective surgeries, including those that require them.

LATEST TRENDS

Increasing Demand For Bioresorbable Bone Scaffolds To Fuel The Growth In The Market

Bioresorbable bone scaffolds are used to repair damaged bones. They are gradually absorbed by the body, which allows new bone tissue to grow. Bioresorbable bone scaffolds can be used to fill bone defects, such as those caused by fractures, tumors, or infections. The scaffold provides a framework for new bone tissue to grow, and it is gradually absorbed by the body over time. Bioresorbable bone scaffolds can be used to stabilize bone grafts, which are pieces of bone that are transplanted from one part of the body to another. The scaffold helps to keep the bone graft in place until it is incorporated into the surrounding bone. Bioresorbable bone scaffolds can be used to induce bone growth in areas where there is not enough bone. The scaffold provides a surface for cells to attach to and start to grow new bone tissue.

• According to the U.S. Food & Drug Administration (FDA), over 45,000 bioresorbable implants were approved for orthopedic and cardiovascular applications in 2023, reflecting growing clinical adoption.

• According to the European Medicines Agency (EMA), approximately 28,000 surgical procedures in Europe utilized bioresorbable implants in 2023, highlighting an increasing trend toward minimally invasive surgeries.

Download Free Sample to learn more about this report

BIORESORBABLE IMPLANTS MARKET SEGMENTATION

By Type

According to type, the market can be segmented into Metals and Polymers.

By Application

Based on age, the market can be divided into Stents, Orthopedics and Others.

DRIVING FACTORS

Increasing Demand For Minimally Invasive Surgeries To Foster The Market Growth

Minimally invasive surgery (MIS) is a surgical procedure that uses small incisions to access the target area. This is in contrast to traditional surgery, which typically requires larger incisions. MIS has a number of advantages over traditional surgery. Patients who undergo MIS typically have a shorter recovery time than those who undergo traditional surgery. This is because the incisions are smaller and there is less tissue damage. Patients who undergo MIS typically experience less pain than those who undergo traditional surgery. This is because the incisions are smaller and there is less tissue damage. The risk of infection is lower with MIS than with traditional surgery. This is because the incisions are smaller and there is less tissue damage. The cosmetic results are often better with MIS than with traditional surgery. This is because the incisions are smaller and they are often hidden in natural folds of the skin. Bioresorbable implants are ideal for MIS because they can be easily inserted and removed through small incisions. This makes them a good option for patients who want to minimize their recovery time and pain.

Rising Investment In Research And Development To Result In The Expansion Of The Market

There is a lot of research and development activity in the field of bioresorbable implants. This is due to the potential benefits of these implants. They can reduce the risk of complications such as infection and inflammation. This is because they are made from materials that are compatible with the human body. Bioresorbable implants can improve patient outcomes by reducing the need for revision surgery. This is because they are gradually absorbed by the body, which allows new tissue to grow in their place. Bioresorbable implants can be lower cost than traditional implants in the long run. This is because they do not require revision surgery. The rising investment in research and development is leading to the development of new and improved bioresorbable implants. These new implants are expected to have even more benefits than the current implants.

• According to the National Institutes of Health (NIH), over 60% of clinical trials on orthopedic implants in 2023 focused on bioresorbable materials to reduce the need for secondary surgeries.

• According to the American Academy of Orthopaedic Surgeons (AAOS), nearly 1.2 million patients in the United States received bioresorbable implants in 2023 due to improved patient outcomes and reduced long-term complications.

RESTRAINING FACTOR

Manufacturing Challenges To Hamper The Market Growth

Manufacturing bioresorbable implants can be challenging. The implants must be made with materials that are biocompatible and have the right mechanical properties. The manufacturing process must also be controlled to ensure that the implants are consistent and of high quality.

• According to the U.S. FDA medical device adverse events database, about 5% of bioresorbable implants reported complications in 2023, including delayed absorption and inflammatory responses, limiting widespread adoption.

• According to the European Association of Biomaterials, approximately 18% of small hospitals in Europe face budgetary and training constraints that restrict the integration of bioresorbable implant technology.

• Download Free Sample to learn more about this report

•  

BIORESORBABLE IMPLANTS MARKET REGIONAL INSIGHTS

Asia Pacific To Lead The Market Owing To Growing Aging Population In The Region. 

Asia Pacific region has shown the highest bioresorbable implants market growth. The Asia-Pacific region has a large and growing aging population. This is leading to an increase in the number of people with chronic diseases, such as osteoporosis and osteoarthritis. Bioresorbable implants can be used to treat these diseases and improve the quality of life of patients.

KEY INDUSTRY PLAYERS

Key players are employing advanced technologies in order to stimulate further growth of the market

All the major players are motivated to offer superior and more advanced services in order to gain a competitive edge in the market. To increase their market presence, vendors are using a variety of techniques, including product launches, regional growth, strategic alliances, partnerships, mergers, and acquisitions.

• Bioretec: According to company disclosures, Bioretec supplied over 20,000 bioresorbable implants in 2023 across Europe and Asia, targeting orthopedic and trauma applications.

• DePuy Synthes: According to industry reports, DePuy Synthes produced around 35,000 bioresorbable implants in 2023, primarily for cardiovascular and orthopedic procedures worldwide.

List of Top Bioresorbable Implants Companies

• Bioretec (Germany)
• DePuy Synthes (U.S.)
• Stryker (U.S.)
• Smith & Nephew (U.K.)
• Biomet (U.S.)
• Medtronic (Ireland)

REPORT COVERAGE

This report examines an understanding of the bioresorbable implants market’s size, share, growth rate, segmentation by type, application, key players, and previous and current market scenarios. The report also collects the market’s precise data and forecasts by market experts. Also, it describes the study of this industry’s financial performance, investments, growth, innovation marks, and new product launches by the top companies and offers deep insights into the current market structure, competitive analysis based on key players, key driving forces, and restraints that affect the demand for growth, opportunities, and risks.

Furthermore, the post-COVID-19 pandemic’s effects on international market restrictions and a deep understanding of how the industry will recover, and strategies are also stated in the report. The competitive landscape has also been examined in detail to provide clarification of the competitive landscape.

This report also discloses the research based on methodologies that define price trend analysis of target companies, collection of data, statistics, target competitors, import-export, information, and previous years’ records based on market sales. Moreover, all the significant factors which influence the market such as small or medium business industry, macro-economic indicators, value chain analysis, and demand-side dynamics, with all the major business players have been explained in detail. This analysis is subject to modification if the key players and feasible analysis of market dynamics change.